Buscar
Mostrando ítems 11-20 de 85
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: Comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study
(BMJ Publishing Group, 2017)
© 2017 Published by the BMJ Publishing Group Limited.Objectives To assess the efficacy and safety of switching from the infliximab reference product (RP; Remicade) to its biosimilar CT-P13 (Remsima, Inflectra) or continuing ...
Consensus-based recommendations for the management of juvenile localised scleroderma
(2019-08-01)
In 2012, a European initiative called Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young ...
Avaliação da efetividade dos medicamentos biológicos para o tratamento da Artrite Reumatoide
(Universidade Federal de Minas GeraisUFMG, 2015-07-09)
Rheumatoid arthritis (RA) is a systemic, chronic and progressive inflammatory disease which affects the synovial membrane of joints. The treatment of RA consists to educate the patient and his family, drug therapy, ...
Efficacy and Survival of Biologic DMARD Therapies As Monotherapy : Real World Data
(American College of RheumatologyGrupo de Reumatología Universidad de Antioquia -GRUA-Malden, Estados Unidos, 2022)
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
(Bmj Publishing Group, 2014-01-01)
Objectives This study compared the efficacy and safety of subcutaneous (SC) versus intravenous (IV) formulations of tocilizumab in patients with rheumatoid arthritis with an inadequate response to disease-modifying ...
Avaliação dos níveis salivares das citocinas do perfil Th1, Th2 e Th17 e condição periodontal de indivíduos com artrite reumatoide em uso de DMADs
(Universidade Federal de PernambucoUFPEBrasilPrograma de Pos Graduacao em Odontologia, 2019)
Antinuclear Antibody (ANA) Testing in Patients Treated With Biological DMARDs: Is It Useful?
(2015)
The appearance of biologic agents for the treatment of diverse autoimmune diseases in particular rheumatoid arthritis at the end of the 1990s changed the treatment of these patients. With the introduction of new agents in ...